{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:06:58Z","timestamp":1791245218704,"version":"4.1.0"},"reference-count":31,"publisher":"Massachusetts Medical Society","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[1988,10,6]]},"DOI":"10.1056\/nejm198810063191403","type":"journal-article","created":{"date-parts":[[2010,7,28]],"date-time":"2010-07-28T21:47:12Z","timestamp":1280353632000},"page":"902-907","source":"Crossref","is-referenced-by-count":325,"title":["Intravenous Immunoglobulin for the Prevention of Infection in Chronic Lymphocytic Leukemia"],"prefix":"10.1056","volume":"319","author":[{"name":"A Randomized, Controlled Clinical Trial Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia*","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"r001","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","volume":"46","author":"Rai","year":"1975","journal-title":"Blood"},{"key":"r002","unstructured":"Bunch C. Management of infection in chronic lymphocytic leukaemia. In: Gale RP, Rai KR, eds. Chronic lymphocytic leukemia: recent progress, future advances. New York: Alan R. Liss, 1987:373\u201381."},{"key":"r003","first-page":"1","volume":"18","author":"Hansen","year":"1973","journal-title":"Scand J Haematol [Suppl]"},{"key":"r004","first-page":"291","volume":"24","author":"Chapel","year":"1987","journal-title":"Semin Hematol"},{"key":"r005","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1136\/bmj.2.5257.920","volume":"2","author":"Fairley","year":"1961","journal-title":"Br Med J"},{"key":"r006","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/1097-0142(19880115)61:2<279::AID-CNCR2820610215>3.0.CO;2-4","volume":"61","author":"Rozman","year":"1988","journal-title":"Cancer"},{"key":"r007","first-page":"327","volume":"12","author":"Rai","year":"1987","journal-title":"Blood Cells"},{"key":"r008","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1600-0609.1985.tb00805.x","volume":"35","author":"Siegbahn","year":"1985","journal-title":"Scand J Haematol"},{"key":"r009","unstructured":"Hill LE. Clinical features of hypogammaglobulinaemia. In: MRC Working Party on Hypogammaglobulinaemia, ed. Hypogammaglobulinaemia in the United Kingdom. Medical research council special report series no. 310. London: Her Majesty's Stationery Office, 1971:9\u201334."},{"key":"r010","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/1097-0142(196203\/04)15:2<307::AID-CNCR2820150214>3.0.CO;2-8","volume":"15","author":"Miller","year":"1962","journal-title":"Cancer"},{"key":"r011","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0090-1229(84)90200-9","volume":"31","author":"Eibl","year":"1984","journal-title":"Clin Immunol Immunopathol"},{"key":"r012","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/BF01642867","volume":"13","author":"Bj\u00f6rkander","year":"1985","journal-title":"Infection"},{"key":"r013","first-page":"683","volume":"65","year":"1986","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"r014","doi-asserted-by":"crossref","first-page":"15S","DOI":"10.1007\/BF00918362","volume":"2","author":"Buckley","year":"1982","journal-title":"J Clin Immunol"},{"key":"r015","unstructured":"Schedel I. Application of immunoglobulin preparations in multiple myeloma. In: Morrell A, Nydegger UE, eds. Clinical use of intravenous immunoglobulins. London: Academic Press, 1986:123\u201332."},{"key":"r016","unstructured":"Dixon WJ, Massey FJ. Introduction to statistical analysis. 4th ed. New York: McGraw-Hill, 1983."},{"key":"r017","unstructured":"Dunn OJ, Clark VA. Applied statistics: analysis of variance and regression. 2nd ed. New York: John Wiley, 1987."},{"key":"r018","doi-asserted-by":"crossref","unstructured":"Cox DR, Lewis PAW. The statistical analysis of series of events. London: Chapman & Hall, 1966.","DOI":"10.1007\/978-94-011-7801-3"},{"key":"r019","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"r020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc [B]"},{"key":"r021","first-page":"163","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"r022","unstructured":"Lee ET. Statistical methods for survival data analysis. Belmont, Calif.: Lifetime Learning Publications, 1980."},{"key":"r023","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2141.1981.tb02727.x","volume":"48","author":"Binet","year":"1981","journal-title":"Br J Haematol"},{"key":"r024","unstructured":"Chapel HM. Hypogammaglobulinaemia and chronic lymphocytic leukaemia. In: Gale RP, Rai KR, eds. Chronic lymphocytic leukemia: recent progress, future advances. New York: Alan R. Liss, 1987:383\u20139."},{"key":"r025","unstructured":"Ochs HD, Morell A, Skvaril F, et al. Survival of IgG subclasses following administration of intravenous gammaglobulin in patients with primary immunodeficiency diseases. In: Morell A, Nydegger UE, eds. Clinical use of intravenous immunoglobulins. London: Academic Press, 1986: 77\u201385."},{"key":"r027","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1537-2995.1986.26486262753.x","volume":"26","author":"Mitra","year":"1986","journal-title":"Transfusion"},{"key":"r028","first-page":"231","volume":"35","year":"1986","journal-title":"MMWR"},{"key":"r029","unstructured":"Berkman SA. AIDS and plasma-derived products in the USA. In: Morell A, Nydegger UE, eds. Clinical use of intravenous immunoglobulins. London: Academic Press, 1986:399\u2013409."},{"key":"r030","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0140-6736(84)91506-X","volume":"2","author":"Lever","year":"1984","journal-title":"Lancet"},{"key":"r031","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0140-6736(85)91430-8","volume":"1","author":"Ochs","year":"1985","journal-title":"Lancet"},{"key":"r032","unstructured":"Lee ML, Courter SG, Tait D, Kingdon HS. Long-term evaluation of intravenous immune globulin preparation with regard to non-A, non-B hepatitis safety. In: Zuckerman AJ, ed. Viral hepatitis and liver disease. New York: Alan R. Liss, 1988:596\u20139."}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJM198810063191403","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T14:52:11Z","timestamp":1740322331000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/abs\/10.1056\/NEJM198810063191403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,10,6]]},"references-count":31,"journal-issue":{"issue":"14","published-print":{"date-parts":[[1988,10,6]]}},"alternative-id":["10.1056\/NEJM198810063191403"],"URL":"https:\/\/doi.org\/10.1056\/nejm198810063191403","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,10,6]]}}}